By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today announced that President and CEO Kevin King is stepping down as of the end of June and will be replaced by former Dionex President and CEO Frank Witney.

Affy said that King was leaving to "pursue other interests."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.